Shares of CASI Pharmaceuticals (NASDAQ:CASI) moved higher by 1.6% in pre-market trading after the company reported Q2 results. Quarterly Results Earnings per share were up 43.75% year over year to ($0.09), which missed the estimate of ($0.08). read more
Foreaders 